CXCR3 + monocytes/macrophages are required for establishment of pulmonary metastases

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Butler, Kiah L ^a,b,c   Clancy Thompson, Eleanor ^a,b,c   Mullins, David W ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCR3 PROTEIN, MOUSE;

ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG TUMOR; MACROPHAGE; MELANOMA; METASTASIS; MONOCYTE; PATHOLOGY; SECONDARY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; LUNG NEOPLASMS; MACROPHAGES; MELANOMA; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NEOPLASM METASTASIS; RECEPTORS, CXCR3; SIGNAL TRANSDUCTION;

EID: 85016591684     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45593     Document Type: Article

References (34)

1. Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-7 (2005).
2. Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-75 (2006).
3. Qian, B. et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 4, e6562 (2009).
4. Headley, M. B. et al. Visualization of immediate immune responses to pioneer metastatic cells in the lung. Nature 531, 513-7 (2016).
5. Kitamura, T. et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasisassociated macrophages. J. Exp. Med. 212, 1043-59 (2015).
6. Williams, C. B., Yeh, E. S. & Soloff, A. C. Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer 2 (2016).
7. Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-40 (2001).
8. Chen, Q., Zhang, X. H.-F. & Massagué, J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 20, 538-49 (2011).
9. Pucci, F. et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood 'resident' monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114, 901-14 (2009).
10. D'Ambrosio, D., Mariani, M., Panina-Bordignon, P. & Sinigaglia, F. Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am. J. Respir. Crit. Care Med. 164, 1266-75 (2001).
11. Clancy-Thompson, E. et al. Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease. Cancer Immunol. Res. 3, 956-67 (2015).
12. Zhu, G. et al. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity. Oncotarget 6, 43408-43419 (2015).
13. Kawada, K. et al. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene 26, 4679-88 (2007).
14. Bai, M., Chen, X. & Ba, Y. I. CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer. Mol. Clin. Oncol. 4, 23-30 (2016).
15. Pradelli, E. et al. Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs. Int. J. Cancer 125, 2586-94 (2009).
16. Kawada, K. et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res. 64, 4010-7 (2004).
17. Jenkins, M. H., Brinckerhoff, C. E. & Mullins, D. W. CXCR3 Signaling in BRAFWT Melanoma Increases IL-8 Expression and Tumorigenicity. PLoS One 10, e0121140 (2015).
18. Walser, T. C. et al. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer. Cancer Res. 66, 7701-7 (2006).
19. Qian, B.-Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51 (2010).
20. Ma, X. et al. CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model. Mol. Cancer Ther. 8, 490-8 (2009).
21. Amatschek, S. et al. CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. Br. J. Cancer 104, 469-79 (2011).
22. Ganss, R., Schütz, G. & Beermann, F. The mouse tyrosinase gene. Promoter modulation by positive and negative regulatory elements. J. Biol. Chem. 269, 29808-16 (1994).
23. Sorensen, M. R., Pedersen, S. R., Lindkvist, A., Christensen, J. P. & Thomsen, A. R. Quantification of B16 melanoma cells in lungs using triplex Q-PCR-a new approach to evaluate melanoma cell metastasis and tumor control. PLoS One 9, e87831 (2014).
24. Taub, D. D. et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177, 1809-14 (1993).
25. Luster, A. D. & Leder, P. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178, 1057-65 (1993).
26. Björkander, S., Heidari-Hamedani, G., Bremme, K., Gunnarsson, I. & Holmlund, U. Peripheral monocyte expression of the chemokine receptors CCR2, CCR5 and CXCR3 is altered at parturition in healthy women and in women with systemic lupus erythematosus. Scand. J. Immunol. 77, 200-12 (2013).
27. García-López, M. A. et al. CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab. Investig. 81, 409-18 (2001).
28. van Rooijen, N. & Sanders, A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174, 83-93 (1994).
29. Paget, S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 8, 98-101 (1989).
30. Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-37 (2013).
31. Goldberg-Bittman, L. et al. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines. Immunol. Lett. 92, 171-178 (2004).
32. Medoff, B. D. et al. CXCR3 and Its Ligands in a Murine Model of Obliterative Bronchiolitis: Regulation and Function. J. Immunol. 176, 7087-7095 (2006).
33. Wightman, S. C. et al. Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome. Br. J. Cancer 113, 327-35 (2015).
34. Mikucki, M. E. et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat. Commun. 6, 7458 (2015).